您现在的位置: 首页> 研究主题> 白喉毒素

白喉毒素

白喉毒素的相关文献在1986年到2022年内共计144篇,主要集中在基础医学、分子生物学、内科学 等领域,其中期刊论文87篇、会议论文5篇、专利文献8751篇;相关期刊58种,包括学生之友(小学版)上、生物技术通报、生物技术通讯等; 相关会议4种,包括中国畜牧兽医学会动物繁殖学分会第十六届学术研讨会、第十次全国生物制品学术会议、第三次全国免疫诊断暨疫苗学术研讨会等;白喉毒素的相关文献由304位作者贡献,包括张国利、洪涛、王健伟等。

白喉毒素—发文量

期刊论文>

论文:87 占比:0.98%

会议论文>

论文:5 占比:0.06%

专利文献>

论文:8751 占比:98.96%

总计:8843篇

白喉毒素—发文趋势图

白喉毒素

-研究学者

  • 张国利
  • 洪涛
  • 王健伟
  • 岳玉环
  • 欧阳晶
  • 朱平
  • 吴广谋
  • 李泽鸿
  • 马伟
  • 吴丽娜
  • 期刊论文
  • 会议论文
  • 专利文献

搜索

排序:

年份

    • 陆瑾; 梁红远; 吴丽娜; 瞿爱东
    • 摘要: 目的 构建重组白喉毒素(diphtheria toxin,DT)与血管内皮生长因子(vascular endothelial growth factor,VEGF)融合蛋白,研究其对裸鼠肿瘤模型的治疗效果.方法 采用PCR扩增法从人外周血淋巴细胞cDNA中获取编码含8-110位氨基酸片段的VEGF8-110基因,并从DT基因中扩增得到编码含1-384位氨基酸片段的DT384基因,将目的基因克隆到质粒载体pET9a中,构建重组表达质粒,转化大肠埃希菌BL21-Plys菌株表达重组蛋白,通过阴离子交换层析和分子筛层析纯化.将滴有融合蛋白的滤纸放到暴露的鸡胚绒毛尿囊膜上,孵育24 h后,观察融合蛋白对鸡胚绒毛尿囊膜的影响.对接种肿瘤1周后的裸鼠进行尾静脉注射治疗,第21天处死裸鼠取下肿瘤,测量其体积和质量,观察融合蛋白对裸鼠肿瘤模型的治疗效果.结果 重组质粒经测序鉴定构建正确.融合蛋白在大肠埃希菌中以包涵体形式表达,包涵体具有高效的复性效果.DT384-VEGF8-110融合蛋白无法抑制鸡胚绒毛尿囊膜上的血管生长,DT384-(VEGF8-110)2融合蛋白可以抑制鸡胚绒毛尿囊膜上的血管生长,也可抑制裸鼠肿瘤生长.经DT384-(VEGF8-110)2融合蛋白治疗接种Bxpc3胰腺癌细胞的裸鼠,其肿瘤平均质量(t=5.908,P<0.001)和平均肿瘤体积(t=4.619,P<0.001)均小于对照组,且差异有统计学意义.结论 DT384-(VEGF8-110)2融合蛋白能够有效抑制裸鼠肿瘤生长.
    • 程金章; 杨景朴; 仲炜; 王海涛; 赵胤; 陈俊俊; 王宗贵; 牙韩盛
    • 摘要: 目的 构建抗CD133单链抗体(scFV)/白喉毒素DAB389融合蛋白,在大肠杆菌里表达,并鉴定及纯化.方法 采用PCR的方法,扩增融合基因DAB389-Linker-CD133 (scFV),并插入到原核表达载体pET28a中,构建了重组表达载体pET28a-DAB389-CD133,融合蛋白在BL21 (DE3)中表达,表达产物经SDS-PAGE鉴定,通过Ni柱纯化目的蛋白,获得了纯度达95%的DAB389-Linker--CD133 (scFV)融合蛋白.Western blot鉴定蛋白活性.流式细胞仪检测能否与CD133抗原特异性结合.结果 扩增的片段与理论值一致,序列分析正确;纯化得到纯度为95%的重组蛋白.Western blot分析能特异性地与抗白喉抗体结合.流式细胞仪检测能与CD133抗原特异性结合.结论 成功构建了抗CD133单链抗体(scFV)/白喉毒素DAB389融合蛋白,具有结合抗原和免疫毒素双重活性,为进一步靶向治疗奠定了基础.
    • 吴丽娜; 陆瑾; 祝婧烨; 徐帆洪; 瞿爱东
    • 摘要: 目的 构建胃泌素多肽G17-白喉毒素A亚单位(diphtheria toxin subunit A,DTA)嵌合蛋白,并初步研究其免疫原性.方法 用酶切法将编码G17的基因与DTA基因连接后,插入载体Pet11c,并在大肠埃希菌BL21中表达.先后用阴离子交换色谱法和分子排阻色谱法对表达的目的蛋白进行纯化.用纯化的G17-DTA免疫NIH小鼠,并用ELISA检测小鼠抗G17抗体.结果 构建的G17-DTA嵌合蛋白可在大肠埃希菌中高效表达,表达量达0.5~0.6 mg/ml菌液.经2次纯化后,G17-DTA的纯度可达95%.纯化的G17-DTA在小鼠中诱生了抗G17抗体.结论 构建的G17-DTA嵌合蛋白能在大肠埃希菌中表达,而且在小鼠中具有免疫原性.%Objective To construct chimeric protein gastrin peptide G17-diphtheria toxin subunit A (DTA) ,and preliminarily study its immunogenicity .Methods After G17-coding gene was linked with DTA gene using enzyme digestion ,G17-DTA fragment was inserted into vector pET11C and expressed in E .coli BL21 .The expressed protein was purified using anion exchange chromatography followed by molecular exclusion chromatography . NIH mice were immunized with the purified G17-DTA , and anti-G17 antibody was detected by ELISA .Results The constructed chimeric protein G17-DTA was highly expressed in E .coli .The amounts of protein were 0 .5-0 .6 mg/ml bacterial solution .The purity of G17-DTA achieved 95% after 2 purifications .NIH mice immunized with G17-DTA produced anti-G17 antibodies .Conclusion The constructed chimeric protein G17-DTA is successfully expressed in E .coli , and has immunogenicity in mice .
    • 潘豪来; 王际平; 冯艳梅; 王慧; 殷善开
    • 摘要: 目的 观察不同剂量白喉毒素对野生型听力成熟小鼠的耳蜗结构及听功能的影响,为建立白喉毒素受体介导的细胞敲除系统动物模型提供参考.方法 4周龄C57BL/6J小鼠30只随机分为50 ng/g组、100 ng/g组和对照组,每组10只;其中50 ng/g组和100 ng/g组小鼠分别单次腹腔注射白喉毒素50 ng/g、100 ng/g,对照组小鼠单次腹腔注射等量生理盐水,注射后7天观察两组动物的一般情况,并记录小鼠ABR反应阈,观察小鼠内外毛细胞、螺旋神经节神经元.结果 在白喉毒素注射后第7天,各组动物情况良好,无明显体重下降,中耳腔无积液.50 ng/g组小鼠2、8、32 kHz ABR反应阈分别为57.5±2.74、20.83±2.04、45.83±2.04 dB SPL,与对照组比较(分别为56.25±2.31、20.0±3.78、49.38±6.78 dB SPL)差异无统计学意义;内、外毛细胞损失率分别为0.8%±0.5%、1%±0.6%;对照组分别为0.3%±0.5%、0.4%±0.3%;螺旋神经节神经元SGN密度为39.45±3.65个/105 μm2、对照组为41.03±3.73个/105 μm2,均未见明显细胞缺失.100 ng/g组小鼠2、8、32 kHz ABR反应阈分别为85±3.54、63±4.47、90±0 dB SPL,较前两组显著升高(t=19.62,P<0.001),内、外毛细胞损失率分别为0.5%±0.1%、10.7%±0.3%,损伤严重,底、中、顶回缺失达10%(t=42.219, P<0.001);SGN密度为25.55±3.66个/105 μm2,平均减少38%,与对照组相比差异有显著统计学意义(t=10.985,P<0.001).结论 100 ng/g白喉毒素注射能引起听力成熟野生型C57BL/6J小鼠外毛细胞及螺旋神经元的损伤.%Objective To investigate the effects of different doses of diphtheria toxin on cochlear structure and auditory function of adult wildtype mice.Methods The auditory-mature wild type C57BL/6J mice 4 weeks old were randomly devided into 50 ng/g group, 100 ng/g group and control group.C57BL/6J mice in the 50 ng/g or 100 ng/g group were injected 50 ng/g or 100 ng/g diphtheria toxin intraperitoneally for one time, respectively, and the control mice were injected equal volume of normal saline for one time.Then we investigated the ABR threshold change and morphological change of inner and outer hair cell and spiral ganglion neuron 7 days after the injection.Results At 7 day post diphtheria toxin injection compared with those of in control group, in the 50 ng/g group, there was no threshold elevation across frequencies(8 kHz ABR threshold was 20.0±3.78 and 20.83±2.04 dB SPL for 50 ng/g and control respectively), and no loss of inner and outer hair cells (for both groups, the HC loss rates were 0.3%~1%) or SGN (the SGN density was 39.45±3.65, 41.03±3.73/105 μm2, in 50 ng/g and control, respectively).However, the 100 ng/g group, compared with those of in control group, the ABR threshold (8 kHz ABR threshold was 63.0±4.47 dB SPL, respectively)was significantly elevated across each frequency(t=19.62,P<0.001), and there was significant loss of outer hair cell (the loss rate of IHC and OHC was 0.5%±0.1%, 10.7%±0.3%, respectively), which was 10% loss in the apical, middle and basal turn(t=42.219,P<0.001).And the loss of spiral ganglion neuron (the SGN density was 25.55±3.66/105 μm2) was 38%, which was significantly different from the control(t=10.985,P<0.001).Conclusion High dose injection of diphtheria toxin can cause loss of outer hair cell and spiral ganglion neuron in wild type auditory-mature C57BL/6J mice.
    • 张景锋; 朱宽佑; 徐秋良; 张长兴; 刘健; 张守全
    • 摘要: 白喉毒素是由感染β噬菌体基因组的白喉棒状杆菌所产生的外毒素,具有极强的毒性,一分子的毒蛋白就可以杀死细胞,目前在肿瘤治疗和动物疾病模型制备过程中得到了广泛的应用.主要对白喉毒素的结构、作用机制及其在肿瘤治疗和动物模型制备过程中的应用进行了综述,旨在为后续相关白喉毒素的研究和应用提供一定的理论基础.
    • 摘要: 美困一项研究发现,当小鼠的嗅觉失灵时,即便食用高脂肪食物,它们也不会发胖。这可能意味着,无法闻到食物会对人的新陈代谢产生影响,令人即便吃高脂肪食物也会保持苗条。研究人员给小鼠服用了常规剂量的白喉毒素,暂时抑制它们的嗅觉,然后为其提供普通食物或会诱发肥胖症的高脂肪食物。3个多月后,
    • 周宇; 赵兆; 袁涛; 李晓容; 李春阳
    • 摘要: 目的:构建白喉毒素(Diphtheria toxin)无毒突变体CRM197(Cross-reacting materials 197)的原核表达载体,并在大肠杆菌中表达重组蛋白。方法以白喉杆菌(ATCC39255)基因组DNA为模版,采用聚合酶链式反应(Poly-merase chain reaction, PCR)扩增 CRM197基因,插入表达载体 pET11b 中,构建重组原核表达质粒 pET11b-CRM197。经双酶切及测序鉴定正确后,重组质粒被转化入大肠杆菌Rosetta 2(DE3) pLysS, IPTG诱导表达,表达产物经SDS-PAGE和Western blot进行鉴定。结果重组表达质粒经双酶切及测序鉴定,结果表明与预期一致;表达的重组蛋白相对分子质量约58000,并可与鼠抗CRM197单克隆抗体特异性结合。结论已成功构建了重组原核表达载体pET11b-CRM197,重组的CRM197蛋白在大肠杆菌中得到了表达,为以该重组突变体作蛋白载体制备结合疫苗奠定了基础。%Objective To construct the prokaryotic expression vector for nontoxic mutant CRM197 of diphtheria toxin and express it in E. coli. Methods CRM197 gene was amplified by PCR using the genomic DNA of diphtheria bacillus strain as a template, and then amplified fragment was inserted into expression vector pET11b. The recombinant plasmid pET11b-CRM197 was identified by the analysis of restriction endonuclease digestion and sequencing, then transformed into E. coli Rosetta2(DE3)pLysS for expression under induction of IPTG. The expressed product was identified by SDS-PAGE and Western blot. Results It is demonstrated that recombinant plasmid pET11b- CRM197 was constructed successfully. The expressed recombinant protein, with a relative molecular mass of about 58000, showed specific binding to mouse mono-clonal antibody against CRM197. Conclusion Recombinant plasmid pET11b- CRM197 was successfully constructed and expressed in E. coli, which laid a foundation for further study on the preparation of conjugate vaccine using recombinant CRM197 as protein carrier.
    • 李泽鸿; 付玉和; 刘莹; 史飞; 刘玉华
    • 摘要: 为获得高活性、副作用小的重组白喉毒素,在免疫毒素药物ONTAK的基础上,从免疫毒素构建、纯化筛选、对动物及人类的活性研究方面出发,对近年来的重组白喉毒素的研究内容进行了汇总分析.重组白喉毒素的构建方式简捷,临床应用效果良好,通过动物实验可用于多种癌症的治疗,因此重组白喉毒素对肿瘤细胞具有靶向特异性、高效性的优点,是靶向治疗癌症的重要研究方向.
  • 查看更多

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号